The Desmoid Tumor Research Foundation- DTRF

JOIN
DTRF’s Virtual Weekend, September 25-27!

LEARN MORE »

#soliloquy-container-17364{opacity:1}#soliloquy-container-17364 li > .soliloquy-caption{display:none}#soliloquy-container-17364 li:first-child > .soliloquy-caption{display:block}

ANNOUNCEMENTS

Breelyn A. Wilky, MD, Discusses Considerations for Desmoid Tumor Patients During the COVID-19 Pandemic

Additional COVID-19 Related Resources

First-of-its-kind global consensus paper on desmoid tumor treatment published!

Learn more.

To Be Announced: Pediatric clinical trial for nirogacestat.

Press Release: Full enrollment of Phase 3 DeFi nirogacestat trial

Press Release: Iterion Therapeutics initiates Tegavivint’s enrollment of Phase 2a

Tegavivint Phase I trial

New England Journal of Medicine Article “Sorafenib for Advanced and Refractory Desmoid Tumors” and DTRF Press Release

Paper published on DTRF’s PRO Tool

ASCO Presentation for Phase II Pazopanib TrialPazopanib versus IV methotrexate/vinblastine in
adult patients

DTRF’s 2019 Grant AwardsGerlinde Wernig, MD, Assistant Professor of Pathology, Standford Univesity School

2019 DTRF Patient Meeting Presentations

Int’l DTRF Desmoid Tumor Research WorkshopSave the date for the Sept 25, 2020 DTRF International Desmoid Tumor Research Workshop

Desmoid Tumour Foundation of CanadaThey donated $100,000 to DTRF research initiatives in 2019!

Click here for archive of UPDATES

From September 25-27th, DTRF will host the 2020 Together We Will Virtual Weekend, which includes opportunities to connect with each other, empower ourselves through education about the latest research and treatment options available, and fund a cure through the RFA Virtual Challenge. Join us! Learn more »

On September 25th, DTRF will host the seventh annual Int’l Research Workshop (VIRTUAL) as part of the Together We Will Virtual Weekend. Medical professionals are invited to join this forum to share research findings, develop new collaborations, bring new scientists into the research field, and work together on new innovations that will lead to new treatments. Learn more »

The RFA Virtual Challenge is an opportunity for participants to fund a cure for desmoid tumors! “Challengers” are encouraged to create a virtual challenge to match their fundraising goal. This virtual summer campaign will culminate in an online ceremony on September 27th, where the community will be highlighted and winners will be recognized! Take the challenge with us! »

DTRF encourages you to join the DTRF Patient Registry in order to facilitate research efforts. With access to your experience as a patient, researchers will be able to continue learning and making new discoveries in the field of desmoid tumors. If you have ever had a desmoid tumor, you can participate.

Published paper »

Learn more »

Because desmoid tumors are so rare, they are often misunderstood. Review commonly asked questions about classification, pregnancy, recurrence and mutation types. This is a great resource for newly-diagnosed patients.

The DTRF and desmoid tumors have been highlighted in the media creating greater awareness of the disease. Patients, physicians and board members have played a key role in this effort.